Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis
- 1 June 2011
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 44 (8-9) , 650-653
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disordersExperimental Neurology, 2010
- Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagementImmunology & Cell Biology, 2008
- T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALSProceedings of the National Academy of Sciences, 2008
- Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell DeathAnnual Review of Immunology, 2008
- T cells in amyotrophic lateral sclerosisEuropean Journal of Neurology, 2008
- Inflammation and the Degenerative Diseases of AgingAnnals of the New York Academy of Sciences, 2004
- Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse modelBrain Research, 2004
- Apoptosis in amyotrophic lateral sclerosis: a review of the evidenceNeuropathology and Applied Neurobiology, 2001
- Autoimmunity and ALS: studies on antibodies to acetylcholinesterase in seraActa Neurologica Scandinavica, 1997
- Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral SclerosisArchives of Neurology, 1993